Literature DB >> 21704727

Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis.

Prajak Sawangsoda1, Jiraporn Sithithaworn, Smarn Tesana, Somchai Pinlaor, Thidarut Boonmars, Eimorn Mairiang, Puangrat Yongvanit, Kunyarat Duenngai, Paiboon Sithithaworn.   

Abstract

Infection by the liver fluke (Opisthorchis viverrini) causes hepatobiliary disease and bile duct cancer (cholangiocarcinoma, CCA) in endemic areas in Southeast Asia. Measurements of humoral immune response particularly parasite-specific antibodies are useful not only for serodiagnosis but they have been implicated as risk factors of CCA. In this study, we used indirect Enzyme Immunosorbent Assay (ELISA) to measure O. viverrini-specific immunoglobulins in serum, urine and saliva and assessed efficacies in diagnosis of opisthorchiasis and evaluated the relationship of antibodies among clinical specimens in a sample population in endemic areas in Khon Kaen, Thailand. By employing the Receiver Operation Characteristics (ROC) analysis, diagnostic efficacy based upon the area under the curve (AUC) revealed that serum, salivary IgG and IgA performed better than urine for diagnosis of opisthorchiasis. Seropositive cases were found in both parasite egg-negative as well as O. viverrini egg-positive groups. The levels of serum IgG correlated with intensity of O. viverrini infection (P<0.05). Diagnostic sensitivities based on serum and salivary IgG, IgA also positively associated with the intensity of infection. Correlations between serum antibodies and those in saliva were found to be greater in egg-negative than egg-positive individuals for O. viverrini. Our findings indicated a complex interrelation between antibody responses in different clinical specimens triggered by liver fluke infection. More comprehensive examinations are needed to determine the potential utility of salivary antibody detection which, in combination with the conventional fecal examination method, may better assist in the identification of individuals with opisthorchiasis. Furthermore, it may provide a better indicator of the risk of disease, particularly CCA.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704727     DOI: 10.1016/j.parint.2011.06.009

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  12 in total

1.  Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis.

Authors:  Chatanun Eamudomkarn; Paiboon Sithithaworn; Jiraporn Sithithaworn; Sasithorn Kaewkes; Banchob Sripa; Makoto Itoh
Journal:  Parasitol Res       Date:  2015-04-17       Impact factor: 2.289

2.  Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.

Authors:  Rutchanee Rodpai; Vor Luvira; Lakkhana Sadaow; Wattana Sukeepaisarnjaroen; Amnat Kitkhuandee; Krisada Paonariang; Oranuch Sanpool; Wannaporn Ittiprasert; Victoria H Mann; Pewpan M Intapan; Paul J Brindley; Wanchai Maleewong
Journal:  Int J Infect Dis       Date:  2021-12-23       Impact factor: 12.074

3.  Meta-genomic analysis of toilet waste from long distance flights; a step towards global surveillance of infectious diseases and antimicrobial resistance.

Authors:  Thomas Nordahl Petersen; Simon Rasmussen; Henrik Hasman; Christian Carøe; Jacob Bælum; Anna Charlotte Schultz; Lasse Bergmark; Christina A Svendsen; Ole Lund; Thomas Sicheritz-Pontén; Frank M Aarestrup
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

4.  Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine.

Authors:  Chanika Worasith; Christine Kamamia; Anna Yakovleva; Kunyarat Duenngai; Chompunoot Wangboon; Jiraporn Sithithaworn; Nattaya Watwiengkam; Nisana Namwat; Anchalee Techasen; Watcharin Loilome; Puangrat Yongvanit; Alex Loukas; Paiboon Sithithaworn; Jeffrey M Bethony
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

Review 5.  Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.

Authors:  Thomas Hughes; Thomas O'Connor; Anchalee Techasen; Nisana Namwat; Watcharin Loilome; Ross H Andrews; Narong Khuntikeo; Puangrat Yongvanit; Paiboon Sithithaworn; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2017-08-10

6.  Enzyme-linked immunosorbent assay for diagnosis of Amphimerus spp. liver fluke infection in Humans.

Authors:  William Cevallos; Manuel Calvopiña; Victoria Nipáz; Belén Vicente-Santiago; Julio López-Albán; Pedro Fernández-Soto; Ángel Guevara; Antonio Muro
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-03-27       Impact factor: 2.743

Review 7.  Liver Fluke-Associated Biliary Tract Cancer.

Authors:  Piyapan Prueksapanich; Panida Piyachaturawat; Prapimphan Aumpansub; Wiriyaporn Ridtitid; Roongruedee Chaiteerakij; Rungsun Rerknimitr
Journal:  Gut Liver       Date:  2018-05-15       Impact factor: 4.519

8.  Validation of an excretory/secretory antigen based-ELISA for the diagnosis of Opisthorchis felineus infection in humans from low trematode endemic areas.

Authors:  Maria Angeles Gómez-Morales; Alessandra Ludovisi; Marco Amati; Edoardo Pozio
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

9.  Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis.

Authors:  Prasert Saichua; Paiboon Sithithaworn; Amar R Jariwala; David J Diemert; David J Deimert; Jiraporn Sithithaworn; Banchob Sripa; Thewarach Laha; Eimorn Mairiang; Chawalit Pairojkul; Maria Victoria Periago; Narong Khuntikeo; Jason Mulvenna; Jeffrey M Bethony
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

Review 10.  Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia.

Authors:  Narong Khuntikeo; Attapol Titapun; Watcharin Loilome; Puangrat Yongvanit; Bandit Thinkhamrop; Nittaya Chamadol; Thidarat Boonmars; Teerachai Nethanomsak; Ross H Andrews; Trevor N Petney; Paiboon Sithithaworn
Journal:  Front Med (Lausanne)       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.